Not Yet RecruitingNot Applicable

Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria

Austria100 participantsStarted 2025-04

Plain-language summary

The HEAL-S study is a non-interventional study with retrospective data analysis. It consists of two parts. First a retrospective analysis based on nucleic acid testing (NAT) results will be performed. Two cohorts (HCV) and (HBV) will be established. Patients falling into one (or both) of the two cohorts will be invited to a prospective linkage-to-care study. In this part, patients are invited to the clinic, where the possibility of hepatitis treatment will be discussed.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The target population for the HCV cohort consists of individuals with detectable plasma HCV RNA at the latest observation. * The target population for the HBV cohort consists of individuals with detectable plasma HBV RNA at any time and no recorded HDV testing or a positive HDV serology. Exclusion Criteria: * No valid SVRN (german: Sozialversicherungsnummer, english: Social insurance number) * No contact details available * Documented Sustained Virological Response (HCV cohort) * Documented assessment of HDV status (HBV cohort)

What they're measuring

Number of HCV patients that can be linked to care

Timeframe: 10/2024 - 10/2026

Number of HDV patients that can be linked to care

Timeframe: 10/2024 - 10/2026

Trial details

NCT IDNCT06834178

SponsorVanessa Stadlbauer-Koellner, MD

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-10

Contact for this trial

Vanessa Stadlbauer, Univ. Prof. Dr.

0043 316 385 vanessa.stadlbauer@medunigraz.at

View on ClinicalTrials.gov More HBV trials